PAX7 and facioscapulohumeral muscular dystrophy: Crucially, however, of the 80.3% of FSHD myocytes that expressed no DUX4 target genes, so making them indistinguishable from control cells, we found that PAX7 target gene repression remained a significant biomarker of FSHD status.